Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-2 of 2 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
2020Predictive biomarkers and patient outcome in platinum-resistant (PLD-Treated) ovarian cancerSousa, Isabel José Dionísio de; Marques, Durval Santos; Príncipe, Catarina; Portugal, Raquel V.; Canberk, Sule; Prazeres, Hugo; Lopes, José Maria; Gimba, Etel Rodrigues Pereira; Lima, Raquel T.; Soares, Paula; Faculty of Medicine, University of Porto, Porto, Portugal.; Department of Oncology, Centro Hospitalar e Universitário de João, Porto, Portugal.; Natural Science Department, Health and Humanities Institute, Fluminense Federal University, Rio das Ostras. Brazil.; Cellular and Molecular Oncobiology Program, Research Coordination, National Institute of Cancer, Rio de Janeiro. Brazil.; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; Cancer Signalling and Metabolism Group, IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.; Department of Biology, Faculty of Sciences, University of Porto, Porto, Portugal.; Department of Pathology, Faculty of Medicine, University of Porto, Porto, Portugal.
2021Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticityBrum, Mariana Concentino Menezes; Ferreira, Luciana Bueno; Rangel, Leticia Batista Azevedo; Maia, Raquel Ciuvalschi; Moraes, Gabriela Nestal de; Gimba, Etel Rodrigues Pereira; Guimarães, Isabella dos Santos; Program of Molecular and Cellular Oncobiology, National Institute of Cancer, Rio de Janeiro. Brazil.; Division of Clinical Research, National Institute of Cancer, Rio de Janeiro, Brazil.; Departament of Pharmaceutical Sciences, Federal University of Espírito Santo, Vitória, Espírito Santo, Brazil.; Stricto Sensu Graduate Program in Oncology, National Institute of Cancer, Rio de Janeiro. Brazil.